Technology
Health
Biotechnology

Retrophin

$18.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.31 (1.68%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Retrophin and other stocks, options, ETFs, and crypto commission-free!

About

Retrophin, Inc. Common Stock, also called Retrophin, is a biopharmaceutical company. Read More It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. Its products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 8, 2008 and is headquartered in San Diego, CA.

Employees
214
Headquarters
San Diego, California
Founded
2008
Market Cap
766.19M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
365.46K
High Today
$18.95
Low Today
$18.34
Open Price
$18.59
Volume
133.48K
52 Week High
$33.00
52 Week Low
$17.53

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Pharmaceutical
US
North America

News

Yahoo FinanceMay 13

Retrophin Appoints Sandra E. Poole to Board of Directors

Ms. Poole brings more than 25 years of biopharmaceutical product development and manufacturing experience to Retrophin SAN DIEGO, May 13, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (RTRX) today announced the appointment of Sandra E. Poole to the Company's Board of Directors, effective immediately. Ms. Poole brings more than 25 years of biopharmaceutical industry experience in manufacturing strategy, including chemistry, manufacturing and controls (CMC), technical operations, and product development from rese...

18
Yahoo FinanceMay 7

Retrophin (RTRX) Reports Q1 Loss, Misses Revenue Estimates

Retrophin (RTRX) delivered earnings and revenue surprises of -75.00% and -5.72%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

25
Yahoo FinanceMay 7

Retrophin, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 7, 2019 / Retrophin, Inc. (NASDAQ: RTRX) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 7, 2019 at 4:30 PM Eastern Time. To listen to the event live or access a replay of the call - visit https://www.investornetwork.com/company/C-1E8A43B4CB677 To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company's profile. About Investor Network Invest...

7

Earnings

-$0.68
-$0.43
-$0.18
$0.07
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Jul 25, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.